Nasdaq panel orders MDJM LTD (UOKA) delisting after low bid-price violation
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
MDJM LTD reports that an independent Nasdaq Hearings Panel has denied its request to reinstate its Nasdaq listing and has determined to delist the Company’s Class A ordinary shares. The decision follows a prior determination after the shares traded at a closing bid price of $0.10 or less for 10 consecutive business days.
The Company had requested a hearing on March 20, 2026, and received the adverse written decision on May 14, 2026. This Form 6-K is also incorporated by reference into MDJM’s existing registration statements on Form F-3 and Form S-8 and the related prospectuses.
Positive
- None.
Negative
- Nasdaq delisting decision: An independent Nasdaq Hearings Panel has denied MDJM LTD’s request to reinstate its listing and determined to delist its Class A ordinary shares, removing the company from a major U.S. trading market.
Insights
Nasdaq delisting removes a key U.S. trading venue for MDJM LTD.
The filing states that an independent Nasdaq Hearings Panel denied MDJM LTD’s request to reinstate its listing and determined to delist its Class A ordinary shares. The trigger was a closing bid price of $0.10 or less for 10 consecutive business days.
Loss of a Nasdaq listing typically reduces share liquidity and visibility in U.S. markets, which can affect how easily investors trade the stock. The report also incorporates this event into the company’s existing Form F-3 and Form S-8 registration statements, meaning those prospectuses now reflect that the shares are no longer listed on Nasdaq.
Key Figures
Low bid-price threshold: $0.10 closing bid
Consecutive days at or below threshold: 10 business days
Nasdaq staff determination letter date: March 13, 2026
+4 more
7 metrics
Low bid-price threshold
$0.10 closing bid
For 10 consecutive business days triggering Nasdaq action
Consecutive days at or below threshold
10 business days
Period with $0.10 or less closing bid price
Nasdaq staff determination letter date
March 13, 2026
Initial notice of suspension and delisting process
Hearing request date
March 20, 2026
Company requested hearing before Nasdaq Hearings Panel
Panel decision date
May 14, 2026
Panel denied reinstatement and determined to delist
Form F-3 file number
333-294010
Registration statement incorporated by reference
Form S-8 file number
333-278269
Registration statement incorporated by reference
Key Terms
foreign private issuer, Nasdaq Hearings Panel, closing bid price, registration statement on Form F-3, +1 more
5 terms
foreign private issuer regulatory
"This report of foreign private issuer on Form 6-K is hereby incorporated by reference into"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Nasdaq Hearings Panel regulatory
"the Company requested a hearing before an independent Nasdaq Hearings Panel (the “Panel”)."
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
closing bid price financial
"the Company’s securities had a closing bid price of $0.10 or less for 10 consecutive business days"
The closing bid price is the last price that a buyer was willing to pay for a security at the end of the trading day. It reflects the final visible demand for the stock — like the last offer someone makes for a used car before a yard closes — and helps investors gauge market interest, set valuations, and mark portfolios to market for that day.
registration statement on Form F-3 regulatory
"into (i) the registration statement on Form F-3 of the Company (File Number 333-294010)"
A registration statement on Form F-3 is a streamlined filing used by eligible foreign companies to register securities for sale in the U.S., often as a “shelf” that lets them offer shares quickly when market conditions are right. For investors it matters because it signals that the company can raise capital on short notice—potentially increasing liquidity but also the risk of share dilution if new stock is issued—similar to a company keeping a pre-approved credit line ready to use.
registration statement on Form S-8 regulatory
"and (ii) the registration statement on Form S-8 of the Company (File Number 333-278269)"
A registration statement on Form S-8 is the U.S. Securities and Exchange Commission filing companies use to register shares they intend to grant to employees, directors, consultants or benefit plans under stock compensation programs. It matters to investors because it signals potential issuance of new shares tied to pay and incentives, which can increase the total shares outstanding — like adding more slices to a pie — reducing each existing share’s ownership and potentially affecting earnings per share and stock value.
FAQ
What did the May 2026 MDJM LTD (UOKA) Form 6-K report?
The Form 6-K reports that an independent Nasdaq Hearings Panel denied MDJM LTD’s request to reinstate its listing and decided to delist its Class A ordinary shares. It also incorporates this information into the company’s existing Form F-3 and Form S-8 registration statements.
Why is MDJM LTD (UOKA) being delisted from Nasdaq?
Nasdaq staff had previously notified MDJM LTD that its securities had a closing bid price of $0.10 or less for 10 consecutive business days. After a hearing request, an independent Nasdaq Hearings Panel issued a written decision on May 14, 2026, denying reinstatement and determining to delist the shares.
When did MDJM LTD (UOKA) receive the Nasdaq delisting decision?
MDJM LTD received the written decision from the independent Nasdaq Hearings Panel on May 14, 2026. That decision denied the company’s request to reinstate its Nasdaq listing and determined that its Class A ordinary shares would be delisted from The Nasdaq Stock Market.
How did MDJM LTD (UOKA) respond after the initial Nasdaq notice?
After receiving a Nasdaq staff determination letter dated March 13, 2026, MDJM LTD requested a hearing before an independent Nasdaq Hearings Panel on March 20, 2026. Despite this request and hearing, the Panel ultimately denied reinstatement and decided to delist the company’s Class A ordinary shares.
Which MDJM LTD (UOKA) registration statements reference this delisting Form 6-K?
The Form 6-K is incorporated by reference into MDJM LTD’s registration statement on Form F-3 (File Number 333-294010), as amended, and its registration statement on Form S-8 (File Number 333-278269), as amended, including the prospectuses outstanding under those registration statements.